Concentriq is an enterprise digital pathology platform that leverages AI to accelerate drug discovery, development, and diagnostics by unifying data, teams, and applications for precision medicine.
Vendor
Proscia
Company Website
Concentriq serves as an enterprise platform designed to advance precision medicine by accelerating drug discovery, development, and diagnostics. It achieves this by unifying data, teams, and applications, empowering pathologists and scientists to fully harness the potential of digital pathology and artificial intelligence with enhanced efficiency and impact. The platform acts as a foundational solution, powering specific products for both clinical operations (Concentriq AP, Concentriq AP-Dx) and therapeutic research and development (Concentriq LS), thereby providing organizations with domain-specific solutions. Concentriq LS functions as a central hub for image-based scientific workflows, spanning from biomarker discovery to early-stage clinical trials. It facilitates collaboration and transforms previously siloed, underutilized data into an AI-optimized digital foundation, enabling teams to utilize proprietary and real-world data alongside powerful AI capabilities like Concentriq Embeddings to expedite the creation of life-saving therapies. Concentriq AP assists laboratories in achieving complete digitization and adopting leading AI applications for precise insights and efficient operations. Concentriq AP-Dx, which holds FDA 510(k) clearance for primary diagnosis, offers pathologists an intuitive experience for viewing, interpreting, and managing whole slide images in various clinical settings, from individual reference laboratories to large hospital systems, supporting late-stage clinical trials and enhancing daily diagnostic workflows. The platform is designed to be future-proof, offering open APIs and partner integrations to enable organizations to leverage emerging technologies and build advanced AI models.
Features & Benefits
- Unified Enterprise Platform
- Unifies data, teams, and applications to accelerate drug discovery, development, and diagnostics in the era of precision medicine.
- Purpose-Built Products
- Powers solutions for both clinical operations (Concentriq AP, Concentriq AP-Dx) and therapeutic R&D (Concentriq LS) with domain-specific capabilities.
- Concentriq LS for R&D
- Serves as a central hub for image-based scientific workflows, transforming siloed data into an AI-optimized digital foundation.
- Drives collaboration and leverages proprietary/real-world data.
- Enables powerful AI capabilities (Concentriq Embeddings).
- Accelerates the development of life-saving therapies.
- Concentriq AP for Lab Digitization
- Enables laboratories to achieve 100% digitization and adopt industry-leading AI applications.
- Provides precise insights.
- Ensures fast, efficient operations.
- Concentriq AP-Dx for Primary Diagnosis
- Offers an intuitive experience for viewing, interpreting, and managing whole slide images, with FDA 510(k) clearance for primary diagnosis.
- Designed for clinical settings of all sizes.
- Helps advance late-stage clinical trials.
- Drives confidence and operational efficiency in everyday diagnostic workflows.
- Future-Proof Open Platform
- Equips organizations to harness the most promising technologies and build AI models.
- Features trusted partner integrations.
- Provides powerful APIs (REST APIs, events, data warehouse, foundation model integrator).
- Extensive Precision Medicine AI Portfolio
- Offers the market’s most comprehensive portfolio of AI applications for research and diagnostics.
- Seamlessly integrates best-in-class AI-powered analysis.
- Enhances both efficiency and outcomes in pathology workflows.
- Cloud Deployment Options
- Provides scalable and flexible cloud deployment for research and diagnostic teams of any size.
- Fast to deploy (up and running in days).
- Cost and effort-efficient compared to on-premise.
- Compliant and secure with 24/7 monitoring and near real-time alerting.
- Automatically scales up or down with workload.